All 14 employees resigned this week from the foundation that funds non-profit legal work in Alberta, and two board members ...

Shares of biopharma company Corcept Therapeutics (NASDAQ:CORT) fell 51.4% in the afternoon session after the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) rejecting ...

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Corcept Therapeutics Inc (Symbol: CORT), where a total of 4,480 contracts have traded so ...

Shares of biopharma company Corcept Therapeutics (NASDAQ:CORT) fell 4.7% in the afternoon session after investor anxiety mounted ahead of a key U.S. Food and Drug Administration (FDA) decision for its ...

A person died Thursday in a crash that shut down two lanes of Interstate 280 in Daly City, according to the California Highway Patrol. Related Articles Gilroy: Father hit by car, dies after dropping ...

Corcept Therapeutics is rated hold due to high binary risk from an imminent Teva lawsuit decision impacting Korlym sales. Exceptional Phase 3 data for relacorilant in platinum-resistant ovarian cancer ...

An elderly man and a woman were killed Wednesday night after their vehicle crashed into the center median on Interstate 280 near State Route 85, authorities sad. Related Articles Gilroy: Father hit by ...

BIRMINGHAM, Ala. (WIAT) — A man who died in a three-vehicle crash on Hwy 280 Sunday morning has been identified. 82-year-old Arlet Griff Moore was traveling on Hwy 280 near Cahaba River Road when he ...

Corcept Therapeutics has shown unexpected KORLYM franchise durability despite generic pressure and legal headwinds. Relacorilant's transition plan faltered after an FDA CRL, delaying lifecycle ...

(KRON) — A 65-year-old woman from Concord was killed in a single-vehicle, DUI crash on Interstate 280 in Daly City on New Year’s Day, according to the California Highway Patrol. CHP responded to the ...

A large exercise of company stock options by Joseph K Belanoff, Chief Executive Officer at Corcept Therapeutics (NASDAQ:CORT) was disclosed in a new SEC filing on December 29, as part of an insider ...